Recruiting NA Anxiety

New treatment option for Anxiety

Official title Measurement of the Hippocampal Theta Rhythm From the Outer Ear Canal

ClinicalTrials.gov ID: NCT03954483

What this study is testing

What is Buspirone 10 Mg Oral Tablet?

Buspirone 10 Mg Oral Tablet is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for anxiety.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
New technologies are needed to help diagnose anxiety disorders. EVestG has facilitated the identification of numerous possible biomarkers of several psychiatric disorders.
  • You might receive a placebo (an inactive treatment) instead of the study drug. You may not know which one you got.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 40. Healthy volunteers may be eligible.

You may be able to join if

  • Males and females who are between 18 and 40 years of age.

You likely can't join if

  • Psychological treatment in the past year or taking any psychiatric drug.
  • Drugs that interact with the study drugs or that have anxiolytic/anxiogenic properties.
  • Antibiotics or natural health products that inhibit/induce CYP3A4 or CYP2D6.
  • History of substance use disorder or family history of substance use disorder.
  • Pregnancy (or breastfeeding), left handedness, or colour blindness.
  • Individuals who have a current diagnosis, or history of, a neurological illness.
See the full eligibility criteria
Who can join
  • Males and females who are between 18 and 40 years of age.
What rules you out
  • Psychological treatment in the past year or taking any psychiatric drug.
  • Drugs that interact with the study drugs or that have anxiolytic/anxiogenic properties.
  • Antibiotics or natural health products that inhibit/induce CYP3A4 or CYP2D6.
  • History of substance use disorder or family history of substance use disorder.
  • Pregnancy (or breastfeeding), left handedness, or colour blindness.
  • Individuals who have a current diagnosis, or history of, a neurological illness.
  • A history of stroke, head injury, loss of consciousness, epilepsy.
  • Kidney or liver disease/impairment.
  • COPD or sleep apnea.
  • Skin lesions involving the ear canal, self-reported or as assessed in examination at the lab.
  • Any unknown balance disorders, as assessed by investigator via balance test.
  • Major hearing loss, self-reported or as assessed by investigator via audiogram.
  • Allergic skin reactions to chemical agents including detergents.
  • Heart disease, lung disease or diabetes.
  • Influenza, Covid-19, or flu-like symptoms.
  • Recovering from an accident, injury, or operation.

The study team makes the final eligibility decision.

Where it's taking place

  • Winnipeg, Manitoba, Canada

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 40 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Winnipeg, Manitoba, Canada. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.